Valuation : Archer Materials Limited

Market Cap 48.42M 34.87M 30.03M 28.23M 25.76M 48.22M 3.3B 334M 130M 1.69B 131M 128M 5.45B P/E 2025
-7.85x
P/E 2026 -12.4x
Enterprise Value 39.98M 28.79M 24.79M 23.31M 21.27M 39.81M 2.72B 276M 107M 1.4B 108M 106M 4.5B EV / Sales 2025
19.9x
EV / Sales 2026 30x
Free-Float
95.22%
Yield 2025 *
-
Yield 2026 -
1 day+4.97%
1 week+8.07%
Current month-3.68%
1 month-14.08%
3 months-53.77%
6 months-45.10%
Current year-39.00%
1 week 0.1
Extreme 0.1046
0.11
1 month 0.1
Extreme 0.1016
0.15
Current year 0.1
Extreme 0.1016
0.28
1 year 0.1
Extreme 0.1016
0.29
3 years 0.1
Extreme 0.1016
0.35
5 years 0.1
Extreme 0.1016
1.35
10 years 0.02
Extreme 0.017
1.62
Manager TitleAgeSince
Chief Executive Officer - 2025-03-26
Corporate Secretary - 2025-05-04
Director TitleAgeSince
Chairman - 2007-02-15
Director/Board Member - 2021-10-05
Director/Board Member - 2025-11-30
Change 5-day change 1-year change 3-year change Capi.($)
+4.97%+8.07% - - 34.9M
+0.84%+5.89%+34.20%+374.88% 5,563B
+0.84%-0.41%+107.76%+332.68% 1,975B
+0.21%-2.95%+16.92%+310.19% 1,703B
+6.10%+8.98%+718.44%+1,344.23% 1,148B
+3.20%-0.36%+520.34%+1,281.71% 891B
+4.69%+2.58%+195.18%+336.34% 780B
-1.35%-6.48% - - 554B
+4.51%+7.07%+289.27%+161.68% 503B
+3.92%+5.45%+86.07% - 269B
Average +2.79%+1.47%+246.02%+591.67% 1,487B
Weighted average by Cap. +1.70%+2.66%+159.09%+501.47%

Financials

2025 2026
Net sales 2.06M 1.48M 1.27M 1.2M 1.09M 2.05M 140M 14.17M 5.5M 71.73M 5.56M 5.44M 231M 2.35M 1.69M 1.46M 1.37M 1.25M 2.34M 160M 16.21M 6.29M 82.06M 6.36M 6.22M 265M
Net income -6.97M -5.02M -4.32M -4.06M -3.71M -6.94M -474M -48.07M -18.65M -243M -18.85M -18.44M -785M -6.36M -4.58M -3.94M -3.71M -3.38M -6.33M -433M -43.86M -17.02M -222M -17.2M -16.83M -716M
Net Debt -13.8M -9.94M -8.56M -8.05M -7.34M -13.74M -939M -95.17M -36.93M -482M -37.33M -36.51M -1.55B -8.44M -6.08M -5.24M -4.92M -4.49M -8.41M -575M -58.22M -22.59M -295M -22.83M -22.34M -950M
Logo Archer Materials Limited
Archer Materials Limited is a quantum technology company building advanced semiconductor devices for quantum computing, quantum sensing, and medical diagnostics. The Company principal activities include technology research and development of the carbon nano onion quantum material (12CQ Project), tunnelling magnetoresistance (TMR) sensor project and graphene-based lab-on-a-chip biosensing chip (biochip) and utilizing semiconductor technology development infrastructure and facilities, research, and development to support technology research and development. The Company is focused on developing its biochip technology, including identifying and developing testing for blood potassium levels, for its first target of hypo- and hyperkalemia detection in chronic kidney disease (CKD) patients. Its biochip marks an inflection point in diagnostics, enabling fast, accurate, and low-cost digital testing.
Employees
-
Date Price Change
26-09-04 €0.1098 +4.97%
26-09-03 €0.1046 -2.79%
26-09-02 €0.1076 -2.89%
26-09-01 €0.1108 -2.81%
26-08-31 €0.1140 +12.20%